GLP1R and diabetic cardiomyopathy: These findings build on previous knowledge by demonstrating not only improvement in oxidative stress parameters but also modulation of mitochondrial and hypoxia-related pathways, thereby bridging GLP-1R agonism with fundamental pathways of diabetic cardiomyopathy [19,20].